Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)
 
 • Company Description   
LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.

Number of Employees: 336

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.93 Daily Weekly Monthly
20 Day Moving Average: 2,000,256 shares
Shares Outstanding: 45.45 (millions)
Market Capitalization: $587.64 (millions)
Beta: 2.40
52 Week High: $15.84
52 Week Low: $3.99
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.21% 0.87%
12 Week 148.65% 117.89%
Year To Date 161.21% 146.71%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
236 FIFTH AVENUE SUITE 400
-
NEW YORK,NY 10001
USA
ph: 866-351-5907
fax: -
marc@lifemd.com http://www.lifemd.com
 
 • General Corporate Information   
Officers
Justin Schreiber - Chief Executive Officer and Chairman
Marc Benathen - Chief Financial Officer
Roberto Simon - Director
John Strawn - Director
Joseph DiTrolio - Director

Peer Information
LifeMD, Inc. (CHCR)
LifeMD, Inc. (ESRX)
LifeMD, Inc. (MYDP)
LifeMD, Inc. (COR)
LifeMD, Inc. (GBCS)
LifeMD, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 53216B104
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 45.45
Most Recent Split Date: 10.00 (0.20:1)
Beta: 2.40
Market Capitalization: $587.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.04 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 323.25
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 2.51
EPS Growth
vs. Year Ago Period: 105.26%
vs. Previous Quarter: 150.00%
Sales Growth
vs. Year Ago Period: 48.83%
vs. Previous Quarter: 2.25%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -15.19
12/31/24 - -27.94
Current Ratio
06/30/25 - -
03/31/25 - 0.82
12/31/24 - 0.81
Quick Ratio
06/30/25 - -
03/31/25 - 0.77
12/31/24 - 0.76
Operating Margin
06/30/25 - -
03/31/25 - -4.58
12/31/24 - -8.89
Net Margin
06/30/25 - -
03/31/25 - -4.58
12/31/24 - -8.89
Pre-Tax Margin
06/30/25 - -
03/31/25 - -4.17
12/31/24 - -8.63
Book Value
06/30/25 - -
03/31/25 - -0.01
12/31/24 - -0.09
Inventory Turnover
06/30/25 - -
03/31/25 - 10.74
12/31/24 - 9.75
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©